
Panelists challenge the belief that testosterone fuels prostate cancer, explain PSA on therapy and TRAVERSE BPH data, and weigh Schedule III status.
Finasteride (Proscar) is indicated for the treatment of symptomatic BPHin men with an enlarged prostate to improve symptoms and to reduce the riskof acute urinary retention and BPH-related surgery.





